Connect with us

Life Sciences

Dante Genomics Launches Avanti Software for a Plug-And-Play Genomic Interpretation That Takes Minutes Instead of Hours

Dante Genomics, a global leader in genomics and precision medicine, launched the beta version of Avanti, the Company’s proprietary B2B software for variant…

Published

on

This article was originally published by AITHORITY
Dante Genomics Launches Avanti Software for a Plug-And-Play Genomic Interpretation That Takes Minutes Instead of Hours

Dante Genomics, a global leader in genomics and precision medicine, launched the beta version of Avanti, the Company’s proprietary B2B software for variant interpretation and report writing at scale. Avanti provides clinicians, geneticists and researchers with a plug-and-play web-based software UI that generates reports in less than five minutes, in parallel, for whole genome, whole exome, target panels and other NGS datasets.

Avanti uses VCF or FASTQ files as an input, and returns full reports on a wide variety of clinical areas, in just few minutes, running in parallel. Avanti software is platform agnostic, meaning no matter what sequencer is used, Avanti returns genomic reports and enhances the genomic offering of doctors and researchers.

AiThority: The 3 Building Blocks to Make AI Accessible

Key features include:

  • Minutes to sign up and generate the first report
  • Plug and Play
  • A catalog of 125 reports
  • Secondary and tertiary analysis
  • Reports generated in parallel, in less than 5 minutes
  • Advanced trio and population analysis available
  • Supports GRCh37 and GRCh38 references in VCF files
  • Advanced set of APIs
  • No integration required. Get up and running in 3 minutes
  • Transparent pricing, No license fees
  • No bioinformatics or computer science background required
  • Compatible with Illumina, PacBio, Oxford Nanopore, Complete Genomics/MGI, Element and Ultima datasets

“We developed our Avanti software to allow the Dante team to have speed and precision at scale and, given the success we’ve seen internally, we decided to make it available externally. With Avanti, clinics and researchers gain the software needed to boost their genomic interpretation,” said Andrea Riposati, CEO of Dante Genomics. “The Avanti customer will not need to worry about expensive license fees or integration processes, nor require specific knowledge on bioinformatics. We built plug and play software to enable genomic and healthcare professionals to be up and running in minutes, gaining the speed and scalability that we leverage at Dante Genomics for complex whole genome sequencing interpretation at scale.”

Read More: How ChatGPT Will Transform Customer Service

[To share your insights with us, please write to sghosh@martechseries.com]

The post Dante Genomics Launches Avanti Software for a Plug-And-Play Genomic Interpretation That Takes Minutes Instead of Hours appeared first on AiThority.

bioinformatics




medicine

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending